All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BAMBOO HEALTH · Healthcare and prescription drug monitoring

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Kentucky · House · Senate · $70,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 2

HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
HR 8845
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027

Lobbying activity 2

Health Issues

Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues related to H.R.8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027.

Medicare/Medicaid

Issues related to behavioral health services and care coordination; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.